Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines

/0 Kommentare/in , , /von

Bottom line and this study out today is telling us what we already knew from prior studies across the last over one year. The study shows that vaccination/injection/inoculation using both mRNA vaccines (Pfizer and Moderna) was related to an increased risk of myocarditis and pericarditis within the first 7 days post vaccination. The study showed that the relationships/associations were especially marked after the second dose, and were existent for both males and females. The study also revealed a trend of enhanced risks towards younger age groups. Moreover, a significant risk was also emerged among males greater than 30 years of age to develop myocarditis and among females over 30 years of age to develop a pericarditis post vaccination.
Specifically, this study (Figures 1 and 2) showed us that for the two vaccines, ‘the risk of myocarditis was increased in the seven days post vaccination. For the BNT162b2 vaccine (Pfizer), odds ratios were 1.8 (95% confidence interval [CI]: 1.3–2.5) for the first dose and 8.1 (95% CI, 6.7–9.9) for the second. The association was stronger for the mRNA-1273 vaccine (Moderna) with odds-ratios of 3.0 (95% CI, 1.4–6.2) for the first dose and 30 (95% CI, 21–43) for the second. The risk of pericarditis was increased in the seven days following the second dose of both vaccines, with odds ratios of 2.9 (95% CI, 2.3–3.8) for the BNT162b2 vaccine and 5.5 (95% CI, 3.3–9.0) for the mRNA-1273 vaccine. Vaccination in the previous 8 to 21 days, with either the BNT162b2 or mRNA-1273 vaccine was not associated with a risk of myocarditis or pericarditis.’

Le Vu et al, Nature Communications, risk includes 10x within just 7 days of taking the vaccine. The absolute risks are considerably greater when the occurrence window is opened. The risks shown are real and are just the tip of the iceberg. Concerning literature.

Age-and-sex-specific-risks-of-myocarditis-and-pericarditis

View PDF Directly: https://www.nature.com/articles/s41467-022-31401-5.pdf

Source: https://www.nature.com/articles/s41467-022-31401-5?utm_source=substack&utm_medium=email

Intramyocardial Inflammation after COVID-19 Vaccination: An Endomyocardial Biopsy-Proven Case Series

/0 Kommentare/in , , /von

Baumeier et al, Berlin, cardiac biopsies reveal giant cell and presence of Spike protein within myocardial tissue. Giant cells are predictive of cardiac death. Presence of Spike evidence of causality for mandated products producing heart damage. @HighWireTalk @fynn fan

Intramyocardial-Inflammation-after-COVID-19-Vaccination

Source: https://www.mdpi.com/1422-0067/23/13/6940

SARS-CoV-2 spike protein expressing epithelial cells promotes senescence associated secretory phenotype in endothelial cells and increased inflammatory response

/0 Kommentare/in , /von

Meyer, St. Louis Univ, Spike causes cells to age more rapidly across an array of in vitro measures. Repeated doses every six months may accelerate the aging process; congruent with reports of increasing and more aggressive cancers and progression of ASCVD. RX ideas in Figure.

Spike-protein-promotes-senescence-associated-secretory-phenotype

View PDF Directly: https://www.biorxiv.org/content/10.1101/2021.04.16.440215v1.full.pdf

Source: https://www.biorxiv.org/content/10.1101/2021.04.16.440215v1

Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein

/0 Kommentare/in , , /von

Van Egeren et al, Harvard, PLOS, explains how mutations render the mandated products useless but still has enough RBD integrity to cause infection.   The worldwide failure of the program occurred with a narrow band of epitopes had no hope for durable protection.  Anticipated.

Risk-of-rapid-evolutionary-escape-from-biomedical-interventions

View PDF Directly: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081162/pdf/pone.0250780.pdf

Source: https://pubmed.ncbi.nlm.nih.gov/33909660/

Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States

/0 Kommentare/in , /von

Corbin et al CIVETs, genetic products essentially useless in HIV. Best to RX viral illness early and avoid complications. Should not rely upon serial administration of ineffective biologicals. Keep HIV as uncomplicated as possible–skilled doctors can manage it it occurs.

Psychotic symptoms post-MRNA vaccine

/0 Kommentare/in , /von

Psychotic symptoms post-MRNA vaccine

Direct PDF: https://www.doctorstalk.ch/wp-content/uploads/2022/06/Psychotic-symptoms-post-MRNA-vaccine.pdf

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349391/

Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination

/0 Kommentare/in , /von

Yahi et al.: so it is the binding to the virus by non-neutralizing Abs that do not eliminate the virus but increases infectiousness…it enhances the infection capability and explains why the vaccinated are getting infected; the non-neutralizing Abs bind to the virus in the upper respiratory tract and drive infection yet binds to the lower respiratory tract and prevents severe disease (transfection from infected to non-infected cells). This study shows original antigenic sin and ADE.

“our data suggest that the balance between neutralizing and facilitating antibodies in vaccinated individuals is in favor of neutralization for the original Wuhan/D614G strain. However, in the case of the Delta variant, neutralizing antibodies have a decreased affinity for the spike protein, whereas facilitating antibodies display a strikingly increased affinity. Thus, ADE may be a concern for people receiving vaccines based on the original Wuhan strain spike sequence (either mRNA or viral vectors).”

Source: https://pubmed.ncbi.nlm.nih.gov/34384810/